Supervisory Board extends contract with Professor Lohse for another five years
The Supervisory Board of ISAR Bioscience has extended the contract with Professor Lohse as Managing Director (Chairman) for another five years. “We are pleased and grateful to have such a recognized scientist at the helm of ISAR Bioscience,” said Supervisory Board Chairman Dr. Manfred Wolter at the signing of the contract. “In a short time and despite the Corona pandemic, he has succeeded in bringing national and international attention to ISAR Bioscience.” Professor Lohse said there are many reasons to be optimistic about the future. “We want to show that the ISAR Bioscience model is the right way to bring basic research discoveries into the development of novel drugs. We are grateful to our university and clinical partners for their collaborative work and are confident that our approach and our work can lead to new therapies and diagnostic procedures.”
